Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

[Analysis of serum levels of nesfatin-1 in children and adolescents with autoimmune thyroid diseases].

Sawicka B, Bossowski A.

Pediatr Endocrinol Diabetes Metab. 2013;19(1):5-10. Polish.

PMID:
23739643
2.

[Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases].

Sawicka B, Bossowski A, Urban M, Szalecki M, Wysocka J, Koput A, Zelazowska-Rutkowska B, Tobolczyk J, Skrzydło M, Rogowski F, Luba M.

Pediatr Endocrinol Diabetes Metab. 2009;15(1):20-7. Polish.

PMID:
19454185
3.

Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.

Sawicka B, Bossowski A, Szalecki M, Wysoka J, Koput A, Zelazowska-Rutkowska B, Tobolczyk J, Rogowski F, Łuba M.

J Pediatr Endocrinol Metab. 2010 Apr;23(4):345-54.

PMID:
20583539
4.

Serum nesfatin-1 levels in overt and subclinical hyperthyroidism.

Gungunes A, Ozbek M, Ginis Z, Sahin M, Demirci T, Cakir Ozkaya E, Karbek B, Sayki Arslan M, Ozturk Unsal I, Tutal Akkaya E, Ucan B, Gultuna Ozguclu S, Cakal E, Topaloglu O, Delibasi T.

Minerva Endocrinol. 2014 Sep;39(3):209-14.

PMID:
25068306
5.

Analysis of serum adiponectin, resistin and leptin levels in children and adolescents with autoimmune thyroid disorders.

Bossowski A, Sawicka B, Szalecki M, Koput A, Wysocka J, Zelazowska-Rutkowska B.

J Pediatr Endocrinol Metab. 2010 Apr;23(4):369-77.

PMID:
20583542
6.

The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.

Abaci A, Catli G, Anik A, Kume T, Bober E.

Pediatr Diabetes. 2013 May;14(3):189-95. doi: 10.1111/pedi.12009. Epub 2013 Jan 24.

PMID:
23346951
7.

Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.

Tohma Y, Akturk M, Altinova A, Yassibas E, Cerit ET, Gulbahar O, Arslan M, Sanlier N, Toruner F.

Thyroid. 2015 Jul;25(7):776-83. doi: 10.1089/thy.2014.0515. Epub 2015 May 19.

PMID:
25915725
8.

Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance.

Anwar GM, Yamamah G, Ibrahim A, El-Lebedy D, Farid TM, Mahmoud R.

Regul Pept. 2014 Jan 10;188:21-4. doi: 10.1016/j.regpep.2013.12.001. Epub 2013 Dec 11.

PMID:
24333832
10.

The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation?

Saldanha JF, Carrero JJ, Lobo JC, Stockler-Pinto MB, Leal VO, Calixto A, Geloneze B, Mafra D.

Regul Pept. 2012 Jan 10;173(1-3):82-5. doi: 10.1016/j.regpep.2011.09.010. Epub 2011 Oct 26.

PMID:
22036920
11.

Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity.

Anık A, Çatlı G, Abacı A, Küme T, Bober E.

J Pediatr Endocrinol Metab. 2014 Jul;27(7-8):623-8. doi: 10.1515/jpem-2013-0475.

PMID:
24825087
12.

A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.

Başar O, Akbal E, Köklü S, Koçak E, Tuna Y, Ekiz F, Gültuna S, Yιlmaz FM, Aydoğan T.

Scand J Clin Lab Invest. 2012 Oct;72(6):479-83. doi: 10.3109/00365513.2012.699097. Epub 2012 Sep 5.

PMID:
22950627
13.

Correlation of Brain Neuropeptide (Nesfatin-1 and Orexin-A) Concentrations with Anthropometric and Biochemical Parameters in Malnourished Children.

Ustabaş Kahraman F, Vehapoğlu A, Özgen İT, Terzioğlu Ş, Cesur Y, Dündaröz R.

J Clin Res Pediatr Endocrinol. 2015 Sep;7(3):197-202. doi: 10.4274/jcrpe.1930.

14.

Association of nesfatin-1 and fat mass in cystic fibrosis.

Cohen RI, Ginsberg N, Tsang D, Wann LC, Ye X, Liu SF.

Respiration. 2013;86(4):312-7. doi: 10.1159/000345375. Epub 2013 Jan 8.

PMID:
23306670
15.

Nesfatin-1 in advanced lung cancer patients with weight loss.

Cetinkaya H, Karagöz B, Bilgi O, Ozgün A, Tunçel T, Emirzeoğlu L, Top C, Kandemir EG.

Regul Pept. 2013 Feb 10;181:1-3. doi: 10.1016/j.regpep.2012.11.005. Epub 2012 Dec 23.

PMID:
23269222
16.

Role of circulating nesfatin-1 in the underweight children with poor appetite.

Kaba S, Karaman K, Kömüroğlu U, A Bala K, Demir N, Kocaman S, Doğan M, Ceylan N.

Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4703-6.

17.

Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.

Guo Y, Xing M, Sun W, Yuan X, Dai H, Ding H.

Acupunct Med. 2014 Aug;32(4):313-7. doi: 10.1136/acupmed-2014-010530. Epub 2014 May 9.

PMID:
24813558
18.

Is There a Relationship between Obstructive Sleep Apnea Syndrome Severity and Nesfatin-1?

Araz O, Yilmazel Ucar E, Dorman E, Bayraktutan Z, Yayla M, Yilmaz N, Acemoglu H, Halici Z, Akgun M.

Respiration. 2015;90(2):105-10. doi: 10.1159/000431180. Epub 2015 Jun 16.

PMID:
26088934
19.

Decreased serum nesfatin-1 levels in endometriosis.

Şengül Ö, Dilbaz B, Halıcı Z, Ferah I, Çadırcı E, Yılmaz F.

Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:34-7. doi: 10.1016/j.ejogrb.2014.03.012. Epub 2014 Mar 15.

PMID:
24702902
20.

NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.

Hofmann T, Stengel A, Ahnis A, Buße P, Elbelt U, Klapp BF.

Psychoneuroendocrinology. 2013 Nov;38(11):2502-10. doi: 10.1016/j.psyneuen.2013.05.013. Epub 2013 Jun 21.

PMID:
23796625

Supplemental Content

Support Center